Company Name: Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company. The company is engaged in the discovery, development, manufacturing and commercialization of medicines for serious conditions. The company’s marketed products include treatments for eye diseases, high LDL cholesterol and Cryopyrin-Associated Periodic Syndromes (CAPS) including Familial Cold Auto-inflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS). The company’s pipeline includes product candidates in a variety of therapeutic areas.
Ticker Symbol: REGN (NASDAQ)
Company Website: www.regeneron.com
Headquarters: Tarrytown, New York